Dr. Bottino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 W Saint Marys Rd
Ste 100
Tucson, AZ 85745Phone+1 520-276-2270Fax+1 520-585-5827
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1980 - 1981
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1978 - 1981
- University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1977 - 1978
- New York Medical CollegeClass of 1977
- Swarthmore CollegeB.A., Biology, 1969 - 1974
- Swarthmore CollegeB.S., Electrical Engineering, 1969 - 1973
Certifications & Licensure
- HI State Medical License 2024 - 2026
- VT State Medical License 2022 - 2026
- AZ State Medical License 2017 - 2025
- CT State Medical License 1999 - 2025
- DE State Medical License 2022 - 2025
- FL State Medical License 2020 - 2025
- MS State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Father Rufin Compassionate Caregiver Award Bridgeport Diocese, 2012
- Excellence in Teaching Award, Teaching appreciation Award NY Medical College, 2005, 2010
- Teaching Appreciation Award NY Medical College, 1998
- Join now to see all
Clinical Trials
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- 80 citationsPhase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.Kenneth A. Foon, Gino C. Bottino, Paul G. Abrams, Mehmet F. Fer, Dan L. Longo
The American Journal of Medicine. 1985-02-01 - 40 citationsAtypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocyte interferonMehmet F. Fer, Gino C. Bottino, Stephen A. Sherwin, John D. Hainsworth, Paul G. Abrams
The American Journal of Medicine. 1984-11-01 - 210 citationsTreatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.Kenneth A. Foon, Stephen A. Sherwin, Paul G. Abrams, Dan L. Longo, Mehmet F. Fer
The New England Journal of Medicine. 1984-11-01
Journal Articles
- Recombinant Alpha Interferon in The Treatment of Diffuse Large Cell Lymphoma Evolving From Pulmonary Lymphoid Granulomatosis Published LetterBottino, G.C., Bottino, J.C., Ballard, H., New York State Journal of Medicine, 1/1/1988
- Immunoglobulin infusions in the Treatment of Chronic Lymphocytic LeukemiaBottino, G.C., Bottino, J.C., Greene, R., Ballard, H., New York State Journal of Medicine, 1/1/1988
- Recombinant Leukocyte A Interferon is not an Effective Agent for the Treatment of Advanced Chronic Lymphocytic LeukemiaBottino, G.C., Sherwin, S.A., Abrams, P.G., Fer, M.F., Longo, D.L., Schoenberger, C.S., Oldham, R.K., Foon, K.A., American Journal of Medicine, 1/1/1985
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A phase II trial of recombinant Alpha interferon for advanced chronic lymphocytic leukemia (CLL).K.A. Foon, G.C. Bottino, P.G. Abrams, M.F. Fer, D.L. Longo, C.S. Schoenberger, and R.K. Oldham, Fredrick, M.D., American Society of Hematology, San Francisco, CA, 1/1/1984
- A phase 1 trial of recombinant leukocyte A interferon administered by intra lesional injection.Abrams, P.G., Sherwin, S.A., Heyman, M.R., St. John, R., Fein, S., Bottino, G.C., Smalley, R., and Oldham, R., Fredrick, M.D., American Society of Clinical Oncology, San Diego, CA, 1/1/1983
- Phase 1S- study of 13- cis- retinoic acid as a biologic modifier in the treatment of disseminated cancer.Bottino, G.C., Maluish, A., Williams, R., Mayer, D., and Sherwin, S.A., Fredrick, M.D., American Society of Clinical Oncology, San Diego, CA, 1/1/1983
- Join now to see all
Other
- Patient care evaluation study; In depth study-Breast Cancer. Northern Westchester Hospital Center, 2000 annual report.Bottino, G.C., Commission on Cancer Annual Report
1/1/2000 - Patient care evaluation study; Prostate Cancer. Northern Westchester Hospital Center, 1999 annual report.Bottino, G.C., Commission on Cancer Annual Report
1/1/1999 - Patient care evaluation study; Small Cell Lung Cancer. Northern Westchester Hospital Center, 1999 annual report.Bottino, G.C., Commission on Cancer Annual Report
1/1/1999 - Join now to see all
Press Mentions
- Dr. Gino Clement Bottino Joins the Oncology Institute of Hope and InnovationJanuary 9th, 2018
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Spanish, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: